High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.4M
$5,431,316
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Other
|
2026-03-10 | $51,806 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Discretionary SellΔOwn -55.7%
2026-03-10
$599,087
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Discretionary SellΔOwn -55.7%
|
2026-03-10 | $599,087 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Other
|
2026-03-09 | $670,200 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Discretionary SellΔOwn -12.8%
2026-03-09
$1,356,072Largex2
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Discretionary SellΔOwn -12.8%
|
2026-03-09 | $1,356,072Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-04 | $120,700 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-04 | $702,114x2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-03 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-03 | $1,380,149Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-02 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-02 | $1,393,894Largex3 | S | Form 4 |